Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
11/09/1999 | CA1340819C Active bacteriophage-free lysin for cheese making |
11/09/1999 | CA1340817C Recombinant flagellin vaccines |
11/09/1999 | CA1340815C Hybridomas producing monoclonal antibodies to new mucin epitopes |
11/08/1999 | WO1999058652A2 Cytotoxin-based biological containment |
11/08/1999 | CA2269148A1 Novel methods for the production of gelatin and full-length triple helical collagen recombinant cells |
11/07/1999 | CA2270405A1 Polymorphisms associated with hypertension |
11/06/1999 | CA2270711A1 Improved production of isoprenoids |
11/04/1999 | WO1999056129A1 Methods of selecting internalizing antibodies |
11/04/1999 | WO1999055917A1 Mixed cell diagnostic systems |
11/04/1999 | WO1999055913A2 Reduced complexity nucleic acid targets and methods of using same |
11/04/1999 | WO1999055912A1 Primer extension methods for detecting nucleic acids |
11/04/1999 | WO1999055910A1 Method of inducing apoptosis in a target cell |
11/04/1999 | WO1999055908A2 Nucleotide sequences for detecting enterohemorrhagic escherichia coli (ehec) |
11/04/1999 | WO1999055906A2 Gene screening methods and related assays |
11/04/1999 | WO1999055905A1 ASSAY FOR METHYLATION IN THE GST-Pi GENE |
11/04/1999 | WO1999055900A2 Gcp |
11/04/1999 | WO1999055899A1 Methods for transducing fusion molecules |
11/04/1999 | WO1999055894A1 Construction of retroviral producer cells from adenoviral and retroviral vectors |
11/04/1999 | WO1999055893A1 Retroviral vectors including modified envelope escort proteins |
11/04/1999 | WO1999055892A1 Use of triplex structure dna sequences for transferring nucleotide sequences |
11/04/1999 | WO1999055891A1 Plant gene that regulates dna methylation |
11/04/1999 | WO1999055890A1 A method for increasing the protein content of plants |
11/04/1999 | WO1999055889A2 Carotenoid biosynthesis enzymes |
11/04/1999 | WO1999055888A2 Carotenoid biosynthesis enzymes |
11/04/1999 | WO1999055887A2 Carotenoid biosynthesis enzymes |
11/04/1999 | WO1999055886A1 Function-based gene discovery |
11/04/1999 | WO1999055885A2 Novel serine protease capable of selective cleavage of insulin-like growth factor binding protein |
11/04/1999 | WO1999055884A1 CLONING AND EXPRESSING THE ASPERGILLUS ORYZAE BGII β-GLUCOSIDASE GENE |
11/04/1999 | WO1999055883A2 Triacylglycerol lipases |
11/04/1999 | WO1999055882A1 Phytic acid biosynthetic enzymes |
11/04/1999 | WO1999055881A1 Cephalosporin deacetylase, gene coding for it, and preparation method of deacetylated cephalosporin compounds using it |
11/04/1999 | WO1999055880A1 Grapevine leafroll virus proteins and their uses |
11/04/1999 | WO1999055879A1 Phytic acid biosynthetic enzymes |
11/04/1999 | WO1999055878A1 Novel nucleic acids and polypeptides related to a farnesyl-directed cysteine carboxymethyltransferase |
11/04/1999 | WO1999055877A1 Microbial preparation of substances from aromatic metabolism/iii |
11/04/1999 | WO1999055876A2 Polypeptide with immunogenic properties and with a protein with modified biological functions |
11/04/1999 | WO1999055875A2 VACCINES CONTAINING RECOMBINANT PILIN AGAINST NEISSERIA GONORRHOEAE OR $i(NEISSERIA MENINGITIDIS) |
11/04/1999 | WO1999055874A2 Nucleic acids of the m antigen gene of histoplasma capsulatum, antigens, vaccines and antibodies, methods and kits for detecting histoplasmosis |
11/04/1999 | WO1999055873A2 Basb006 polynucleotide(s) and polypeptides from neisseria meningitis |
11/04/1999 | WO1999055872A1 Basb013 dna and proteins from neisseria meningitidis |
11/04/1999 | WO1999055871A1 Polypeptides from moraxella (branhamella) catarrhalis |
11/04/1999 | WO1999055870A2 Transcription and gene expression regulators |
11/04/1999 | WO1999055869A1 Novel polypeptide growth factors and materials and methods for making them |
11/04/1999 | WO1999055868A2 Fizz proteins |
11/04/1999 | WO1999055867A1 Delayed rectifier potassium channel subunit |
11/04/1999 | WO1999055866A1 Delivery of therapeutic proteins via implantation of genetically modified cells in the omentum |
11/04/1999 | WO1999055865A1 Polynucleotides isolated from skin cells and methods for their use |
11/04/1999 | WO1999055864A1 NOVEL POLYPEPTIDE, cDNA ENCODING THE SAME AND UTILIZATION THEREOF |
11/04/1999 | WO1999055863A1 NOVEL POLYPEPTIDE, cDNA ENCODING THE SAME AND UTILIZATION THEREOF |
11/04/1999 | WO1999055862A2 Human proteins having transmembrane domains and dnas encoding these proteins |
11/04/1999 | WO1999055861A2 Fibroblast growth factor mutein compositions and methods of use therefor |
11/04/1999 | WO1999055860A1 Host-encoded protein expressed on marek's disease (mdv)-infected cells and antibody thereto |
11/04/1999 | WO1999055859A2 Cd40-interacting and traf-interacting proteins |
11/04/1999 | WO1999055858A2 Human nucleic acid sequences obtained from pancreas tumor tissue |
11/04/1999 | WO1999055857A2 Nucleoside triphosphates and their incorporation into ribozymes |
11/04/1999 | WO1999055856A2 Nucleic acid enzyme for rna cleavage |
11/04/1999 | WO1999055855A2 Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth |
11/04/1999 | WO1999055854A2 Insulin-like growth factor ii antisense oligonucleotide sequences and methods of using same to modulate cell growth |
11/04/1999 | WO1999055852A1 Apolipoprotein e transgenic animals and assay methods |
11/04/1999 | WO1999055851A2 Site-directed transformation of plants |
11/04/1999 | WO1999055847A2 Enzymatic nucleic acids molecules which modulate the expressions and/or replication of hepatitis c virus |
11/04/1999 | WO1999055846A1 Recombinant secoisolariciresinol dehydrogenase, and methods of use |
11/04/1999 | WO1999055845A1 Cellular and animal models for diseases associated with altered mitochondrial function |
11/04/1999 | WO1999055844A2 Methods for modulating differentiation |
11/04/1999 | WO1999055841A2 Process for obtaining stem cells |
11/04/1999 | WO1999055840A1 A transcription factor and method for regulation of seed development, quality and stress-tolerance |
11/04/1999 | WO1999055832A2 Nucleic acid encoding rate agouti related protein |
11/04/1999 | WO1999055831A2 Adenoviral vectors for treating disease |
11/04/1999 | WO1999055829A2 Process for preparing doxorubicin |
11/04/1999 | WO1999055825A1 A process of making a compound by forming a polymer from a template drug |
11/04/1999 | WO1999055735A1 G-csf receptor agonist antibodies and screening method therefor |
11/04/1999 | WO1999055734A1 A g-protein coupled 7tm receptor (axor-1) |
11/04/1999 | WO1999055733A1 Cloning of a novel 7tm receptor axor-2 |
11/04/1999 | WO1999055732A1 A novel g-protein coupled receptor |
11/04/1999 | WO1999055730A2 Polyepitope carrier protein |
11/04/1999 | WO1999055729A1 STAPHYLOCOCCUS AUREUS pyrH POLYPEPTIDES AND POLYNUCLEOTIDES |
11/04/1999 | WO1999055720A1 Targeted gene delivery to cells by filamentous bacteriophage |
11/04/1999 | WO1999055564A1 Materials and methods for gene therapy |
11/04/1999 | WO1999055380A1 Nr-CAM GENE, NUCLEIC ACIDS AND NUCLEIC ACID PRODUCTS FOR THERAPEUTIC AND DIAGNOSTIC USES FOR TUMORS |
11/04/1999 | WO1999055379A1 A process of delivering a polynucleotide to a cell via the vascular system |
11/04/1999 | WO1999055378A1 Method of treating endotoxemia |
11/04/1999 | WO1999055369A1 Monoclonal antibodies with reduced immunogenicity |
11/04/1999 | WO1999055368A1 Regulation of biofilm formation |
11/04/1999 | WO1999055367A1 INTERNALIZING ErbB2 ANTIBODIES |
11/04/1999 | WO1999055365A1 Adenoviral vectors with tandem fiber proteins |
11/04/1999 | WO1999055364A2 Proteins that direct the secretion of virulence proteins and vaccines comprising them |
11/04/1999 | WO1999055345A1 Combination viral-based and gene-based therapy of tumors |
11/04/1999 | WO1999055343A1 Cnre binding factors and uses thereof |
11/04/1999 | WO1999055132A2 Generation of packaging system for human recombinant adenoviral vectors |
11/04/1999 | WO1999047671A3 Dna sequences encoding semaphorin-h and diagnosis of metastatic cancer |
11/04/1999 | WO1999046381A3 Human fgf gene and gene expression products |
11/04/1999 | WO1999046377A3 A human vanilloid receptor-like cation channel |
11/04/1999 | WO1999046372A3 Ribozymes capable of inhibiting the expression of the ccr5 receptor |
11/04/1999 | WO1999045114A3 Human semaphorin zsmf-7 |
11/04/1999 | WO1999045112A3 Chromosome 11-linked coronary heart disease susceptibility gene chd1 |
11/04/1999 | WO1999044063A3 Tumor tissue microarrays for rapid molecular profiling |
11/04/1999 | WO1999042597A9 Monovalent, multivalent, and multimeric mhc binding domain fusion proteins and conjugates, and uses therefor |
11/04/1999 | WO1999042595A9 Mismatch cleavage enzymes from extreme thermophiles and uses thereof |
11/04/1999 | WO1999042594A9 Fungus and insect control with chitinolytic enzymes |
11/04/1999 | WO1999042585A9 Compositions containing an ox-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response |